Detalhe da pesquisa
1.
Allogeneic haemopoietic cell transplant services in Australia and New Zealand in the first year of the COVID-19 pandemic: a report from Australia and New Zealand transplant and cellular therapies.
Intern Med J
; 53(3): 323-329, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35833788
2.
Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID-19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cell.
Intern Med J
; 53(1): 119-125, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36371767
3.
Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statement.
Intern Med J
; 51(8): 1321-1323, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34423546
4.
Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic.
Intern Med J
; 50(6): 667-679, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32415723
5.
CD56bright natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-versus-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results.
Haematologica
; 102(11): 1936-1946, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28935847
6.
Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study.
Biol Blood Marrow Transplant
; 22(8): 1410-1415, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27154847
7.
Bone Marrow Transplant Society of Australia and New Zealand COVID-19 consensus position statement.
Intern Med J
; 50(6): 774-775, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32537929
8.
Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with Acute Myeloid Leukemia and Myelodysplastic Syndromes Demonstrates Long Term Survival, Results from Australia and New Zealand Transplant and Cellular Therapies.
Transplant Cell Ther
; 30(3): 334.e1-334.e7, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38029962
9.
The association of socioeconomic deprivation with access and survival after hematopoietic stem cell transplantation in New Zealand.
Asia Pac J Clin Oncol
; 19(2): e89-e95, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35692102
10.
Incidence of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease and Treatment with Defibrotide in Allogeneic Transplantation: A Multicenter Australasian Registry Study.
Transplant Cell Ther
; 29(6): 383.e1-383.e10, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36934993
11.
Erratum to "Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study" [Biol Blood Marrow Transplant 2016;22:1410-1415].
Biol Blood Marrow Transplant
; 23(3): 534, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27789277
13.
Staphylococcus haemolyticus meningitis and bacteremia in an allogenic stem cell transplant patient.
IDCases
; 26: e01259, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34485080
14.
Treatment outcomes of patients with acute promyelocytic leukaemia between 2000 and 2017, a retrospective, single centre experience.
Leuk Res
; 93: 106358, 2020 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32380366
15.
Early treatment of acute promyelocytic leukaemia is accurately guided by the PML protein localisation pattern: real-life experience from a tertiary New Zealand centre.
Pathology
; 51(4): 412-420, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30876657
16.
Allogeneic hematopoietic cell transplant for multiple myeloma using reduced intensity conditioning therapy, 1998-2006: factors associated with improved survival outcome.
Leuk Lymphoma
; 52(9): 1727-35, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21864043
17.
Novel sequence insertion in a Mâori patient with transfusion-dependent beta-thalassaemia.
Br J Haematol
; 131(3): 400-2, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16225661
18.
Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma.
Br J Haematol
; 131(2): 223-30, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16197454
19.
Giant actin inclusions in hematopoietic cells: a variant of Brandalise syndrome?
J Pediatr Hematol Oncol
; 24(9): 781, 2002 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12468927